761
Views
10
CrossRef citations to date
0
Altmetric
Letters to the Editor

Prognosis of MECOM (EVI1)-rearranged MDS and AML patients rather depends on accompanying molecular mutations than on blast count

, , , , &
Pages 1756-1759 | Received 05 Feb 2020, Accepted 26 Feb 2020, Published online: 19 Mar 2020
 

Acknowledgements

The authors would like to thank all co-workers at the MLL Munich Leukemia Laboratory for approaching together many aspects in the field of leukemia diagnostics and research by their dedicated work, as well as all physicians for providing samples and caring for patients as well as collecting data.

Disclosure statement

CH, WK, and TH declare part ownership of Munich Leukemia Laboratory (MLL). IS, AS, and MM are employed by the MLL Munich Leukemia Laboratory.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.